SLC5A2 and type 2 diabetes mellitus: Skin sodium levels, which are closely associated with left ventricular mass [47], are increased in patients with T2DM [48] and SGLT2 inhibition reduced skin sodium levels (without osmotic activity) in T2DM patients [49].